163 related articles for article (PubMed ID: 31751649)
1. Chinese medicine Xiaoshui decoction inhibits malignant pleural effusion in mice and mediates tumor-associated macrophage polarization by activating autophagy.
Jin Z; Shen C; Zhang H; Qi R; Guo Q; Liu R; Hua B; Shi Z
J Ethnopharmacol; 2020 Mar; 249():112412. PubMed ID: 31751649
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Controlled Study to Observe the Efficacy of External Treatment With a Traditional Chinese Medicine Herbal Ointment on Malignant Plural Effusion: Outcome Report and Design Review.
Feize W; Meng L; Yanni L; Yuan L; Liqun J; Tong L; Guowang Y; Huijuan C; Donggui W; Zhiqiang C; Lei Z
Integr Cancer Ther; 2017 Dec; 16(4):473-478. PubMed ID: 27431570
[TBL] [Abstract][Full Text] [Related]
3. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
[TBL] [Abstract][Full Text] [Related]
4. Clinical observation on the efficacy of Xiaoshui decoction combined with intrapleural perfusion of cisplatin in treating malignant pleural effusion.
SHI Z; HE QY; HUA BJ
Chin J Integr Med; 2008 Dec; 14(4):257-61. PubMed ID: 19082796
[TBL] [Abstract][Full Text] [Related]
5. S100A9 Regulated M1/M2 Macrophage Polarization in Interleukin-10-Induced Promotion of Malignant Pleural Effusion.
Pei XB; Yi FS; Dong SF; Chen QY; Shi XY
J Immunol Res; 2023; 2023():3473464. PubMed ID: 37533789
[TBL] [Abstract][Full Text] [Related]
6. Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion.
Magkouta S; Pappas A; Moschos C; Vazakidou ME; Psarra K; Kalomenidis I
Oncotarget; 2016 Apr; 7(15):20249-59. PubMed ID: 26959120
[TBL] [Abstract][Full Text] [Related]
7. The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
Wu MF; Lin CA; Yuan TH; Yeh HY; Su SF; Guo CL; Chang GC; Li KC; Ho CC; Chen HW
Cancer Immunol Immunother; 2021 May; 70(5):1435-1450. PubMed ID: 33175182
[TBL] [Abstract][Full Text] [Related]
8. CSF1/CSF1R signaling mediates malignant pleural effusion formation.
Kosti CN; Vaitsi PC; Pappas AG; Iliopoulou MP; Psarra KK; Magkouta SF; Kalomenidis IT
JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315360
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and experimental study of xiaoshui decoction in the treatment of primary liver cancer caused ascites].
Wu D; Bao WG; Ding YH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Dec; 25(12):1066-9. PubMed ID: 16398423
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
[TBL] [Abstract][Full Text] [Related]
11. The effect of Jianpi Yangzheng Xiaozheng Decoction and its components on gastric cancer.
Wu J; Zhang XX; Zou X; Wang M; Wang HX; Wang YH; Li CY; Zhao LG; Chen M; Pei LX; Liu SL; Sun QM
J Ethnopharmacol; 2019 May; 235():56-64. PubMed ID: 30731181
[TBL] [Abstract][Full Text] [Related]
12. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
[TBL] [Abstract][Full Text] [Related]
13. Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.
Li L; Yang L; Wang L; Wang F; Zhang Z; Li J; Yue D; Chen X; Ping Y; Huang L; Zhang B; Zhang Y
Int J Cancer; 2016 Nov; 139(10):2261-9. PubMed ID: 27459735
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism.
Lu Y; Lin H; Zhai K; Wang X; Zhou Q; Shi H
Sci China Life Sci; 2016 Dec; 59(12):1297-1304. PubMed ID: 27535421
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutical effects of pleural injecting recombinant human endostain to
malignant pleural effusion nude mice model].
Zhou M; Li M; Yang H; Hu C
Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):266-71. PubMed ID: 25975296
[TBL] [Abstract][Full Text] [Related]
16. Haimufang decoction, a Chinese medicine formula for lung cancer, arrests cell cycle, stimulates apoptosis in NCI-H1975 cells, and induces M1 polarization in RAW 264.7 macrophage cells.
Ma WP; Hu SM; Xu YL; Li HH; Ma XQ; Wei BH; Li FY; Guan HS; Yu GL; Liu M; Liu HB
BMC Complement Med Ther; 2020 Aug; 20(1):243. PubMed ID: 32758223
[TBL] [Abstract][Full Text] [Related]
17. CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.
Wang F; Yang L; Gao Q; Huang L; Wang L; Wang J; Wang S; Zhang B; Zhang Y
Cancer Immunol Immunother; 2015 Aug; 64(8):965-76. PubMed ID: 25944005
[TBL] [Abstract][Full Text] [Related]
18. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.
Liu Y; Wang L; Song Q; Ali M; Crowe WN; Kucera GL; Hawkins GA; Soker S; Thomas KW; Miller LD; Lu Y; Bellinger CR; Zhang W; Habib AA; Petty WJ; Zhao D
Nat Nanotechnol; 2022 Feb; 17(2):206-216. PubMed ID: 34916656
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 signaling inhibits malignant pleural effusion by altering Th1/Th17 responses.
Xu QQ; Zhou Q; Xu LL; Lin H; Wang XJ; Ma WL; Zhai K; Tong ZH; Su Y; Shi HZ
Cell Biol Int; 2015 Oct; 39(10):1120-30. PubMed ID: 25939739
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y
PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
